Citi Pharma Reports 7% Profit Growth in FY25 and Announces 35% Cash Dividend
Citi Pharma Limited achieved a 7% profit increase in FY25, posting Rs892 million net profit and announcing a 35% cash dividend, supported by strong sales growth, operational efficiency, and strategic cost management.